EFFECTS OF MATERNAL GESTATIONAL DIABETES AND ADIPOSITY ON NEONATAL ADIPOSITY AND BLOOD-PRESSURE

Citation
Br. Vohr et al., EFFECTS OF MATERNAL GESTATIONAL DIABETES AND ADIPOSITY ON NEONATAL ADIPOSITY AND BLOOD-PRESSURE, Diabetes care, 18(4), 1995, pp. 467-475
Citations number
30
Categorie Soggetti
Endocrynology & Metabolism","Medicine, General & Internal
Journal title
ISSN journal
01495992
Volume
18
Issue
4
Year of publication
1995
Pages
467 - 475
Database
ISI
SICI code
0149-5992(1995)18:4<467:EOMGDA>2.0.ZU;2-G
Abstract
OBJECTIVE -- To determine the effects of maternal factors, including p repregnancy maternal adiposity, weight gain during pregnancy, degree o f abnormality of the glucose tolerance test, glycemia during pregnancy , and treatment with insulin versus diet therapy, on neonatal body wei ght, adiposity, and blood pressure in infants of mothers with gestatio nal diabetes (IGDM) and control patients. RESEARCH DESIGN AND METHODS- A total of 119 term IGDM, including 57 large-for-gestational-age (LGA) and 62 appropriate-for-gestational-age (AGA) infants, and 143 term co ntrol infants, including 74 LGA and 69 AGA infants, were prospectively enrolled. Maternal measurements of prepregnancy weight, height, and w eight gain were abstracted from medical records. A diagnosis of gestat ional diabetes was made on the basis of an initial 1-h 50-g glucose sc reen value greater than or equal to 130 mg/dl followed by two abnormal values in a 100-g oral glucose tolerance test. Infant anthropometric measurements were obtained, and blood pressure was measured on day 2 o f life. Correlation analyses and multiple regression analyses were per formed to assess the relationships among maternal factors and neonatal adiposity and blood pressure. RESULTS-Multiple regression analyses to determine the effects of significant maternal factors on infant body mass index (BMI) revealed that prepregnancy weight and weight gain wer e significant predictors for both IGDM and control infants. An increas ed glucose screen predicted BMI for control subjects, whereas the mean 2nd and 3rd trimester glucose values were the significant predictors for IGDM. Also, increased newborn triceps skinfold thickness measureme nts correlated with increased systolic blood pressure for IGDM (r = 0. 29, P < 0.03). CONCLUSIONS-Increased maternal prepregnancy weight, wei ght gain in pregnancy, and glycemia in pregnancy all place IGDM at inc reased risk of macrosomia and adiposity. Increased adiposity in the IG DM appears to be related to increased infant blood pressure. Longitudi nal evaluation is needed to determine whether neonatal adiposity in IG DM is predictive of increased adiposity and blood pressure during chil dhood.